发明授权
US06878705B2 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents
失效
4-氧代-4,7-二氢呋喃并[2,3-b]吡啶-5-甲酰胺抗病毒剂
![4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents](/docs/US/2005-04-12/US06878705B2/abs.jpg.600x600.jpg)
- 专利标题： 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents
- 专利标题（中）： 4-氧代-4,7-二氢呋喃并[2,3-b]吡啶-5-甲酰胺抗病毒剂
-
申请号： US10345062申请日： 2003-01-14
-
公开(公告)号： US06878705B2公开(公告)日： 2005-04-12
- 发明人: Michele M. Cudahy , Mark E. Schnute , Steven P. Tanis , William R. Perrault , Paul Matthew Herrinton , Sajiv K. Nair
- 申请人： Michele M. Cudahy , Mark E. Schnute , Steven P. Tanis , William R. Perrault , Paul Matthew Herrinton , Sajiv K. Nair
- 申请人地址： US NJ Bridgewater
- 专利权人： Pfizer
- 当前专利权人： Pfizer
- 当前专利权人地址： US NJ Bridgewater
- 代理机构： Schwegman, Lundberg, Woessner & Kluth, P.A.
- 主分类号： C07D491/048
- IPC分类号： C07D491/048 ; A61K31/4355 ; A61K31/437 ; A61K31/444 ; A61K31/4741 ; A61K31/497 ; A61K31/506 ; A61K31/517 ; A61K31/52 ; A61K31/5377 ; A61P9/10 ; A61P31/12 ; A61P31/22 ; A61P43/00 ; C07D491/02 ; C07D491/04 ; C07D519/00
![4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents](/abs-image/US/2005/04/12/US06878705B2/abs.jpg.150x150.jpg)
摘要：
The invention provides a compound of formula I: wherein G, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of treating a herpesvirus infection using such compounds or salts.
公开/授权文献
信息查询
